
About Spry Therapeutics Private Limited
Data last updated:
Spry Therapeutics Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Spry Therapeutics Inc. and recognised as a startup by DPIIT. It operates in the wellness and healthcare centers segment of the travel and hospitality sector. It was incorporated on 29 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85300MH2021PTC359727. Its GSTIN is 27ABGCS0029M1Z6 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Brijraj Bhuptani and Riyaz Rehman.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 18 Sangam B Wing Four Bunglows Haridwar Marg North Mumbai Suburban, Maharashtra, India – 400061.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.15 Cr, a growth of 86% compared to the previous year. For the same year it recorded a net profit of ₹2.35 Cr (net margin 7.8%) and EBITDA of ₹3.5 Cr (EBITDA margin 11.6%). Revenue has grown at a compounded annual rate (CAGR) of 132% over three years.
The company has about 300 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SPRY. The company has 2 deals on record (2 secondary share transfers); the latest was in September 2021. The company has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 6 overdue payments to 2 micro and small suppliers.
For more details, the company can be reached via its website sprypt.com.
Company details
Recognitions & Rankings of Spry Therapeutics
Contact details
Spry Therapeutics Private Limited's registered office is in Mumbai, Maharashtra. Its website is sprypt.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address18 Sangam B Wing Four Bunglows Haridwar Marg North Mumbai Suburban, Maharashtra, India – 400061
- IndustryTravel and Hospitality, Wellness & Healthcare Centers
To see the full contact details of Spry Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Spry Therapeutics operates one associated brand: SPRY. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Cloud-based practice management is provided for physical therapy clinics. | sprypt.com |
Business activity
The main business activity of Spry Therapeutics is information and communication. In detail, this covers other information & communication service activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J8 | Other information & communication service activities |
To see the full business activity and turnover split of Spry Therapeutics Private Limited, buy the company report.
Financials of Spry Therapeutics Private Limited
FY 2025 filings availableSpry Therapeutics Private Limited reported revenue of ₹30.15 Cr (up 86% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 132% over three years, including 86% growth in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.5 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.35 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 11.6% | |||
| Net Profit Margin | 7.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Spry Therapeutics Private Limited, buy the company report.
Board of directors of Spry Therapeutics Private Limited
Spry Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brijraj Bhuptani Also directs: Veex Tech Solution India Private Limited | Director | 29 Apr 2021 | 5 Years 6 Months | Current |
| Riyaz Rehman Also directs: Design Bytes Private Limited | Director | 29 Apr 2021 | 5 Years 6 Months | Current |
Auditor
Spry Therapeutics Private Limited is audited by Manohar Chowdhry & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Manohar Chowdhry & Associates | FY 2022 | 001997S |
Shareholding
The shareholding of Spry Therapeutics Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Spry Therapeutics Private Limited, buy the company report.
Deals & funding
Spry Therapeutics Private Limited has 2 deals on record (2 secondary share transfers); the latest was in September 2021.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2021 | Secondary share transfer | Undisclosed | Buyer: Spry Therapeutics Inc. Seller: 2 individuals |
| Aug 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Spry Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Spry Therapeutics Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 6 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Medulla Communications Private Limited | |||
| Startup Movers Private Limited |
To see the full MSME payment records of Spry Therapeutics Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Spry Therapeutics Private Limited has a workforce of 300 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 300 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Spry Therapeutics Private Limited, buy the company report.
GST
Spry Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABGCS0029M1Z6 | Maharashtra | Active | 11 Jun 2021 |
To see the full GST registrations and return filing status of Spry Therapeutics Private Limited, buy the company report.
Recent activity
Spry Therapeutics Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Brijraj Bhuptani was appointed as Director on 29 Apr 2021.
Frequently asked questions
Spry Therapeutics is an active private limited company based in Mumbai, Maharashtra, India. The company works in wellness and healthcare centers, within the travel and hospitality industry. It was incorporated on 29 April 2021 (5+ years old) and is registered under CIN U85300MH2021PTC359727.
Spry Therapeutics has 2 current directors:
- Brijraj Bhuptani - Director
- Riyaz Rehman - Director
The latest financial statements of Spry Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Spry Therapeutics is 27ABGCS0029M1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Spry Therapeutics is U85300MH2021PTC359727. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spry Therapeutics was incorporated on 29 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Spry Therapeutics has 2 deals on record (2 secondary share transfers); the latest was in September 2021.
Brijraj Bhuptani was appointed as Director on 29 Apr 2021. Riyaz Rehman was appointed as Director on 29 Apr 2021.
Yes, Spry Therapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Spry Therapeutics has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 6 overdue payments to 2 micro and small suppliers. The latest return was filed on 30 Aug 2023.
Spry Therapeutics can be reached through the website sprypt.com. Its registered office is in Mumbai, Maharashtra, India.

